Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cleveland BioLabs updates progress of entolimod pre-EUA review

March 17, 2016

Narcan now available in U.S. for the treatment of opioid overdose

Feb. 26, 2016

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Feb. 23, 2016

FDA extends Probuphine NDA review date

Feb. 22, 2016

EMA grants orphan drug status for entolimod as a radiation countermeasure

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

NIDA to conduct research on RespireRx compounds to treat drug abuse and addiction

Jan. 20, 2016

FDA advisory committee recommends approval of Probuphine

Jan. 13, 2016

Dysregulation of KDM6B has a role in alcohol dependence

Jan. 4, 2016

Initiation of phase III trial of CAM-2038 in opioid-dependent patients

Dec. 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...